Skip to main content

Table 1 GEO studies used to validate DeSigN prediction

From: DeSigN: connecting gene expression with therapeutics for drug repurposing and development

GEO reference Drug Response Number of sensitive samples Number of resistant samples Platform Reference
GSE4342 Gefitinib Sensitive 17 12 GPL96 Coldren et al. [24]
GSE16179 Lapatinib Sensitive 3 3 GPL570 Liu et al. [35]
GSE9633 Dasatinib Sensitive 11 5 GPL571 Wang et al. [36]
GSE35141 Gemcitabine Resistant 6 6 GPL4133 Saiki et al. [37]